NYSE American - Delayed Quote USD

Cryo-Cell International, Inc. (CCEL)

9.22 +0.28 (+3.13%)
At close: June 7 at 3:58 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. David I. Portnoy Chairman & Co-CEO 1.45M -- 1963
Mr. Mark L. Portnoy Co-CEO & Director 990k -- 1964
Ms. Jill M. Taymans CFO & VP of Finance 254.77k -- 1970
Mr. Oleg Mikulinsky Chief Information Officer 382.77k -- 1973
Dr. Joanne Kurtzberg M.D. Medical Director and Member of Medical & Scientific Advisory Board -- -- --

Cryo-Cell International, Inc.

700 Brooker Creek Boulevard
Suite 1800
Oldsmar, FL 34677
United States
813 749 2100 https://www.cryo-cell.com
Sector: 
Healthcare
Full Time Employees: 
82

Description

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, auto-immune diseases, multiple sclerosis, Alzheimer's disease, Parkinson's diseases. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. Cryo-Cell International, Inc. was incorporated in 1989 and is headquartered in Oldsmar, Florida.

Corporate Governance

Cryo-Cell International, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

July 12, 2024 at 10:59 AM UTC - July 16, 2024 at 12:00 PM UTC

Cryo-Cell International, Inc. Earnings Date

Recent Events

April 15, 2024 at 12:00 AM UTC

10-Q: Periodic Financial Reports

March 26, 2024 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

February 28, 2024 at 12:00 AM UTC

10-K: Periodic Financial Reports

October 12, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

September 15, 2023 at 12:00 AM UTC

ARS: Annual Report to Shareholders

September 14, 2023 at 12:00 AM UTC

DEF 14A: Proxy Statements

August 25, 2023 at 12:00 AM UTC

8-K: Corporate Changes & Voting Matters

July 14, 2023 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 21, 2023 at 12:00 AM UTC

10-Q: Periodic Financial Reports

April 14, 2023 at 12:00 AM UTC

NT 10-Q: Periodic Financial Reports

Related Tickers